GoHealth Inc. (GOCO) — Financial statements
Income statement, balance sheet, and cash flow for GoHealth Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 362↓54.7% | 799↑8.7% | 735↑16.3% | 632↓40.5% | 1,062 | |
| Cost of Revenue | 96↓26.4% | 131↓17.8% | 159↓15.3% | 188↓21.6% | 239 | |
| Gross Profit | 266↓60.2% | 668↑16.1% | 576↑29.7% | 444↓46.1% | 823 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 91↑10.6% | 82↓11.8% | 93↓20.1% | 117↑18.7% | 98 | |
| Selling & Marketing Expenses | 116↓50.6% | 236↑15.0% | 205↓1.2% | 208↓43.2% | 365 | |
| SG&A Expenses | 207↓34.8% | 318↑6.6% | 298↓8.0% | 324↓30.1% | 463 | |
| Other Expenses | 211↓40.8% | 358↓0.5% | 359↓18.1% | 439↓48.4% | 849 | |
| Operating Expenses | 419↓38.0% | 675↑2.7% | 657↓13.8% | 763↓41.9% | 1,313 | |
| Total Costs & Expenses | 515↓36.1% | 806↓1.3% | 816↓14.1% | 950↓38.8% | 1,552 | |
| Operating Results | ||||||
| Operating Income | -153↓2070.3% | -7↑91.4% | -82↑74.4% | -319↑34.9% | -489 | |
| Depreciation & Amortization | 80↓24.3% | 106↑0.1% | 106↓1.2% | 107↓0.5% | 108 | |
| EBITDA | -334↓292.1% | 174↑620.7% | 24↑111.4% | -212↑46.2% | -393 | |
| EBIT | -414↓710.1% | 68↑183.1% | -82↑74.4% | -319↑36.4% | -501 | |
| Interest & Other Income | ||||||
| Net Interest Income | -87↓19.8% | -73↓4.9% | -69↓21.7% | -57↓70.3% | -34 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 87↑19.8% | 73↑4.9% | 69↑21.7% | 57↑70.3% | 34 | |
| Non-Operating Income | 261↑448.4% | -75↓202232.4% | -0.04↑67.8% | -0.12↓101.0% | 11 | |
| Other Income / Expenses | -348↓17551.1% | 2↑102.9% | -69↓21.9% | -57↓27.2% | -45 | |
| Income Before Tax | -501↓9818.6% | -5↑96.7% | -151↑59.8% | -376↑29.7% | -534 | |
| Income Tax Expense | -3↓247.1% | 2↑1372.1% | 0.15↓79.8% | 0.76↑3283.3% | -0.02 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -498↓6700.9% | -7↑95.2% | -151↑59.8% | -376↑29.5% | -534 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -257↓8681.6% | -3↑95.4% | -63↑57.5% | -149↑21.5% | -189 | |
| Bottom-Line Net Income | -261↓3861.9% | -7↑90.1% | -67↑55.3% | -150↑21.0% | -189 | |
| EPS (Basic) | -20.17↓2956.1% | -0.66↑90.8% | -7.19↑59.4% | -17.72↑34.0% | -26.85 | |
| EPS (Diluted) | -20.17↓2956.1% | -0.66↑90.8% | -7.19↑59.4% | -17.72↑34.0% | -26.85 | |
| Weighted Average Shares | 13↑29.7% | 10↑7.4% | 9↑10.0% | 8↑19.5% | 7 | |
| Weighted Average Diluted Shares | 13↑29.7% | 10↑7.4% | 9↑10.0% | 8↑19.5% | 7 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.